Variable free and total valproic acid concentrations in sole- and multi-drug therapy

Area of Science:

• Pharmacology
• Clinical Chemistry

Background:

• Valproic acid (VPA) is a widely used antiepileptic drug.
• Serum VPA concentrations can vary significantly based on therapeutic regimens.
• Understanding VPA pharmacokinetics is crucial for optimizing patient outcomes.

Purpose of the Study:

• To compare total and free valproic acid (VPA) serum concentrations in patients receiving VPA as monotherapy versus polytherapy.
• To investigate the influence of concomitant medications on VPA levels.
• To highlight the importance of monitoring VPA levels in clinical practice.

Main Methods:

• Serum samples were collected from patients on sole VPA therapy (SOLE Group) and multiple drug therapy (MULTI Group).
• Total and free VPA concentrations were measured at predose (minimum) and postdose (maximum) time points.
• Statistical analysis was performed to compare VPA levels between the two groups.

Main Results:

• Significantly higher total and free VPA levels were observed in the SOLE Group compared to the MULTI Group.
• Free VPA fractions were also significantly higher in patients on sole therapy.
• VPA levels demonstrated considerable variation, influenced by concomitant drug use and dosing intervals.

Conclusions:

• VPA serum concentrations, both total and free, are significantly affected by whether the drug is administered as monotherapy or polytherapy.
• The nonlinear binding of VPA necessitates careful monitoring of both total and free levels, especially considering potential drug interactions and dosing timing.
• Clinical interpretation of VPA dosage requirements benefits from monitoring levels alongside side effects and seizure control.